OA05.05: ctDNA Predicts Molecular Oligometastatic NSCLC Before LCT | WCLC 2024 Highlights

17 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Explore key findings from abstract OA05.05, presented at WCLC 2024. This study shows how pre-local consolidative therapy (LCT) circulating tumor DNA (ctDNA) can help define molecular oligometastatic NSCLC, offering a potential biomarker to guide treatment decisions more precisely.

Learn how ctDNA profiling before LCT could reshape patient selection and improve outcomes in NSCLC care.

????️ Don't forget to like, share, and subscribe for more cutting-edge updates in lung cancer research.

#NSCLC #ctDNA #WCLC2024 #LungCancer #Oligometastatic #CancerBiomarkers #Oncology #LCT #CancerResearch
Categoria
Oncology
Commenta per primo questo video.

Prossimo